Ankylosing spondylitis
Conditions
Interventions
Chinese medicine group and Western medicine group:Drug intervention
Sponsors
Gansu Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
52 Years to 18 Years
Inclusion criteria
Inclusion criteria: (1) meeting the diagnostic criteria of Western medicine; (2) meeting the dialectical criteria of traditional Chinese medicine diagnosis; (3) aged 18 to 50 years old; (4) voluntarily participating in clinical research and signing informed consent form; (5) The judgment criteria for the disease activity were BASDAI=4 and spine pain score =4; (6) Approved by the Medical Ethics Committee of Gansu Provincial Hospital of Traditional Chinese Medicine: Sulfasalazine methotrexate , Leflunomide, to be discontinued after 1 month before entering the group; the use of biological agents need to be discontinued more than 3 months before enrollment; use of non-steroidal anti-inflammatory drugs, need to be discontinued after 2 weeks before enrollment.
Exclusion criteria
Exclusion criteria: (1) those who do not meet the inclusion criteria; (2) pregnant women or lactating women in pregnancy or in the near future; (3) other seronegative spondyloarthropathies; (4) patients with advanced spinal rigidity and severe joint deformities; ) With acute ophthalmia need corticosteroid treatment; (6) those who can not tolerate the test drug; (7) merger heart, cerebrovascular, liver, kidney and hematopoietic system and other serious primary diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| asessment in ankylosing spondylitis,ASAS; | — |
Countries
China
Contacts
Public ContactSu Xiaojun
Gansu Provincial Hospital of Traditional Chinese Medicine
Outcome results
None listed